Abstract
Of 1,470 patients treated with neuroleptics during 1 year at a private psychiatric hospital, only one patient developed neuroleptic malignant syndrome--an annual frequency of 0.07%. Use of low doses of neuroleptics may account for this frequency, which is below recent estimates.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antipsychotic Agents / administration & dosage
-
Antipsychotic Agents / adverse effects
-
Bipolar Disorder / drug therapy
-
Chlorpromazine / administration & dosage
-
Chlorpromazine / adverse effects
-
Hospitals, Psychiatric*
-
Humans
-
Length of Stay
-
Male
-
Neuroleptic Malignant Syndrome / epidemiology*
-
Neuroleptic Malignant Syndrome / etiology
-
Risk Factors
Substances
-
Antipsychotic Agents
-
Chlorpromazine